Chilean berry producer Agroberries will invest around €40 million to expand its farming operations into Morocco and support its fast-growing European marketing platform.
Agroberries announced it had begun planting in Morocco of around 300 hectares of blueberries in three different regions.
The company hopes to expand its grower network by licensing its proprietary varieties across a range of berry categories to reach around 1,000 hectares.
One of the largest berry marketers in the world, Agroberries supplies customers with produce from its farming operations of over 2,500 hectares worldwide and a vast network of third-party growers.
Jorge Varela, Agroberries co-founder and CEO, described their investment in Morocco as a natural next step to their global expansion plan. He added that the investment leverages their deep agronomical expertise, and partnership approach to help them continue supplying their European customers.


Parents abused by their children often suffer in silence – specialist therapy is helping them find a voice
Glastonbury is as popular than ever, but complaints about the lineup reveal its generational challenge
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
UK Starting Salaries See Strongest Growth in 18 Months as Hiring Sentiment Improves
AI is driving down the price of knowledge – universities have to rethink what they offer
The pandemic is still disrupting young people’s careers
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Australian Household Spending Dips in December as RBA Tightens Policy
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination
Yen Slides as Japan Election Boosts Fiscal Stimulus Expectations
Columbia Student Mahmoud Khalil Fights Arrest as Deportation Case Moves to New Jersey
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 



